For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.
Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...
20don MSN
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold ...
Hosted on MSN1mon
Tenecteplase No Longer Off-Label as Stroke LyticThe FDA approved tenecteplase (TNKase) for adult stroke patients, Genentech announced on Monday. A clot-dissolving tissue plasminogen activator (tPA), tenecteplase is now indicated for acute ...
A new clot-busting drug for stroke works as well as a decades-old drug Patients given tenecteplase had similar outcomes to ...
Acute ischemic stroke, which occurs due to a blockage in cerebral blood flow, requires prompt intervention with thrombolytic ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
The US Food and Drug Administration (FDA) has approved the thrombolytic tenecteplase (TNKase, Genentech) for treatment of acute ischemic stroke in adults. The drug is administered as a single, 5 ...
Please provide your email address to receive an email when new articles are posted on . TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said.
The researchers observed no significant differences between tenecteplase and alteplase in terms of effectiveness or safety outcomes for the overall cohort after adjustment for covariates.
New Clot-Busting Drug Quicker And As Effective In Treating Stroke By Dennis Thompson HealthDay Reporter THURSDAY, March 20, 2025 (HealthDay News) -- A newly approved clot- busting drug for stroke ...
No significant difference seen in terms of effectiveness or safety outcomes, including functional independence at discharge. (HealthDay News) — For patients with ischemic stroke, tenecteplase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results